CHHL yields 1000000.00% · JNJ yields 2.13%● Live data
📍 CHHL pulled ahead of the other in Year 1
Combined, CHHL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHHL + JNJ for your $10,000?
China Holdings, Inc., a development stage company, focuses to engage in the land and real estate development, energy, renewable energy, resources, utilities, and pharmaceutical businesses. The company, through its subsidiary, China Power, Inc., focuses on the mergers and acquisitions, investment, research and development, construction, and operation of energy, renewable energy, and environment protection projects, as well as develops renewable energy projects, pipelines in biomass energy projects, and hydropower plants in China and worldwide. China Holdings, Inc., through its another subsidiary, China Minerals Holdings, Inc., focuses to engage in the exploration, development, and production of precious and rare metals resource and properties, including vanadium, molybdenum, and uranium. In addition, the company, through its subsidiary, China Health Holdings, Inc., focuses on the development, manufacture, marketing, and distribution of pharmaceutical drugs and dietary supplements in China and worldwide. The company was formerly known as China Health Holding, Inc. and changed its name to China Holdings, Inc. in May 2007. China Holdings, Inc. was founded in 2002 and is headquartered in Las Vegas, Nevada.
Full CHHL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.